Treatment of CD33 Related Diseases and Disorders

siRNA and antisense oligonucleotides targeting CD33, for conditions associated with CD33 mutations.

Filings

1

Status

Pending

First priority

Oct 21, 2024

• 2024 siRNA and antisense oligonucleotides targeting CD33 Priority Oct 21, 2024 WO2026090085A1

RNA Therapeutics